NephroQuiz: a fishy rash.

A 51-year-old man presented for evaluation of a newly developed rash (xerosis with hyperpigmented scaly lesions on his arms, legs, abdomen, and back). Skin biopsy showed hyperkeratosis with non-necrotising granulomas. He had no medical history, did not report any nausea, vomiting, chest pain, dyspnea, or urinary symptoms. On examination his blood pressure was 125/75 mmHg, pulse rate was 85 beats per minute, and his oxygen saturation was 96%.
Laboratory investigations showed creatinine 6.27 mg/dL (normal range 0.67–1.17; a baseline measurement 2 months before he presented was 0.9), sodium 137 mmol/L (normal range 136–145), potassium 3.8 mmol/L (normal range 3.5–5.1), bicarbonate 22 mmol/L (normal range 22–29), calcium 15.1 mg/dL (normal range 8.6–10.2), albumin 4.3 g/dL (normal range 3.5–5.2), ionized calcium 1.91 mmol/L (normal range 1.17–1.38), parathyroid hormone (PTH) 9.1 pg/mL (normal range 18.4–80.1), PTH-related protein 3.4 pmol/L (normal range 0.0–2.3), 1,25-dihydroxyvitamin D 97.3 pg/mL (normal range 19.9–79.3), and angiotensin-converting enzyme 120 U/L (normal range 16–85).
Urinalysis was positive for proteinuria with a urine protein-to-creatinine ratio of 0.92. Further serology workup showed the following: negative hepatitis B virus, hepatitis C virus, and HIV serologies, normal C3 and C4, undetectable antinuclear antibodies (ANAs), anti-double stranded DNA antibodies titer of <1:10 (normal <1:10), negative antineutrophil cytoplasmic antibodies (ANCAs), serine protease 3 antibodies (PR3-ANCAs) titer of 0 AU/mL (normal 0–19), myeloperoxidase antibodies (MPO) titer of 0 AU/mL (normal 0–19), and phospholipase A2 receptor (PLA2R) antibody titer of <1:10 (normal <1:10).
Kidney biopsy (shown above) was performed with: light microscopy hematoxylin and eosin stain (A), light microscopy periodic acid methenamine silver stain (B), IgG Immunofluorescence microscopy (C), electron microscopy (D).
The correct answer and explanation will be revealed once you select an answer in the multiple choice question above.
Click here to read the original case report. We encourage discussion of the case and questions in the comments.
Follow the Topic
-
BMC Nephrology
This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Artificial intelligence in nephrology
BMC Nephrology welcomes submissions to a Collection on Artificial intelligence in nephrology.
Current research trends in nephrology represent the beginning of a new era of cross-disciplinary informational synthesis. With accelerating discoveries in genetics, molecular pathways, biochemical interactions and intercellular communication, new potential therapeutic targets are being introduced at an unprecedented rate. With application of novel methods in translational research and vast accumulation of clinical data, personalized treatment regimens have become central in advancing the quality of care and improving outcomes. Innovations in dialysis and transplant management, artificial kidney development, implementation of early diagnostic and disease prevention strategies are at the forefront of a modern patient-centered approach in nephrology.
The continuous flow of novel and constantly evolving information requires a powerful resource for high-level data synthesis and complex analysis in order to find meaning in a perpetually expanding informational field. Artificial Intelligence (AI) technologies, including Machine Learning (ML) are such resources, application of which in clinical and translational research is gaining momentum. The AI generated data-based knowledge has potential to impact patient management strategies by forming support systems for clinical decisions, improving drug design, risk identification and personalization of treatment. In all possible ways, AI and ML are enabling the emergence of “intelligent nephrology”.
This Collection gathers researchers with interest in kidney diseases from different perspectives, from basic science to clinical settings, including bioengineers and data scientists, aiming to present novel strategies of analysis to unravel the causes of renal diseases and improving in personalized therapeutics with the goal of achieving precision medicine. We encourage contributions with focus on the role of AI in novel data acquisition, synthesis, and interpretation, in scope with the journal’s aims in the diagnosis and treatment of renal diseases.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 10, 2025
Pediatric chronic kidney disease: Transitioning into adult care
BMC Nephrology invites submissions to the collection exploring various aspects of this transition from childhood to adulthood including but not limited to:
Transitional care models: Exploring effective strategies
RISE to Transition program: Evaluating its impact
Pediatric to adult services integration: Challenges and solutions
Disease awareness among adolescents with CKD: Bridging gaps
Health-related quality of life in transitioning patients: Assessments and interventions
Enhancing self-management skills in young adults with CKD
Optimizing adult CKD services for transitional patients
Pediatric nephrology: Setting the stage for successful transitions
Multidisciplinary approaches to CKD transitional care
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: May 12, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in